Stryker Ortho Tech — Net Sales increased by 4.7% to $646.00M in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong market demand for orthopedic procedures and successful adoption of the company's implant technologies, while a decrease may signal competitive pressure or a slowdown in elective surgical volumes.
This metric represents the total revenue generated from the sale of orthopedic technology products, including reconstruc...
Comparable to orthopedic segment revenues reported by major medical device competitors like Zimmer Biomet or Smith & Nephew, focusing on reconstructive and trauma product lines.
syk_segment_ortho_tech_net_sales| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $617.00M | $646.00M |
| QoQ Change | — | +4.7% |
| YoY Change | — | +4.7% |